Company Medpace Holdings, Inc.

Equities

MEDP

US58506Q1094

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 24/05/2024 BST 5-day change 1st Jan Change
390.6 USD -0.01% Intraday chart for Medpace Holdings, Inc. -0.70% +27.41%

Business Summary

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Number of employees: 5,800

Sales per Business

USD in Million2022Weight2023Weight Delta
Oncology
31.1 %
468 32.0 % 587 31.1 % +25.50%
Other
21.5 %
297 20.3 % 405 21.5 % +36.35%
Metabolic
20.0 %
245 16.8 % 377 20.0 % +54.01%
Cardiology
10.3 %
175 12.0 % 194 10.3 % +10.91%
Antiviral and Anti-infective
8.7 %
118 8.1 % 163 8.7 % +38.36%
Central Nervous System
8.5 %
158 10.8 % 160 8.5 % +1.34%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
98.0 %
1,431 98.0 % 1,848 98.0 % +29.17%
International
2.0 %
29 2.0 % 38 2.0 % +29.17%

Managers

Managers TitleAgeSince
Chief Executive Officer 67 30/06/92
Director of Finance/CFO 49 31/10/18
President 49 30/09/07
Chief Tech/Sci/R&D Officer - 30/09/21
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 63 31/08/17
Chief Operating Officer 61 31/07/93
Compliance Officer 54 31/05/12
Investor Relations Contact - -
Sales & Marketing - 31/07/13

Members of the board

Members of the board TitleAgeSince
Director/Board Member 72 12/08/18
Chief Executive Officer 67 30/06/92
Director/Board Member 64 12/08/18
Director/Board Member 53 30/06/16
Director/Board Member 70 30/06/16
Director/Board Member 62 15/01/23
Director/Board Member 42 16/05/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,053,472 25,498,423 ( 82.11 %) 70,073 ( 0.2257 %) 82.11 %

Shareholders

NameEquities%Valuation
5,397,412 17.42 % 2 104 M $
Vanguard Fiduciary Trust Co.
8.083 %
2,504,314 8.083 % 976 M $
BlackRock Advisors LLC
7.525 %
2,331,509 7.525 % 909 M $
Wasatch Advisors, Inc.
3.145 %
974,415 3.145 % 380 M $
Invesco Advisers, Inc.
2.633 %
815,801 2.633 % 318 M $
696,959 2.249 % 272 M $
Riverbridge Partners LLC
1.957 %
606,250 1.957 % 236 M $
TD Asset Management, Inc. (13F Subfiler)
1.853 %
574,149 1.853 % 224 M $
Geode Capital Management LLC
1.719 %
532,749 1.719 % 208 M $
Goldman Sachs Asset Management LP
1.705 %
528,418 1.705 % 206 M $

Company contact information

Medpace Holdings, Inc.

5375 Medpace Way

45227, Cincinnati

+513 579 9911

http://www.medpace.com
address Medpace Holdings, Inc.(MEDP)
  1. Stock Market
  2. Equities
  3. MEDP Stock
  4. Company Medpace Holdings, Inc.